References
- US Census Bureau. Annual population estimates by sex, race and Hispanic origin. US Census Bureau, population division, 2001
- US Census Bureau. Population projections of the United States by age, sex, race, and Hispanic origin: 1995 to 2050. Population report P25-1130. Available at: http://www.census.gov/prod/www/abs/popula.html. Accessed Nov 8, 2004
- US Census Bureau. The Hispanic population in the United States: March 1993. Washington, DC: US Government Printing Office, 1993; population report P20-475
- Hanis CL, Ferrell RE, Baron SA, et al. Diabetes among Mexican Americans in Starr County, Texas. Am J Epidemiol 1983; 118(5): 659–72
- Stern MP, Gaskill SP, Hazuda HP, et al. Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study. Diabetologia 1983; 24(4): 272–7
- Hamman RF, Marshall JA, Baxter J, et al. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 1989; 129(2): 295–311
- Burke JP, Williams K, Haffner SM, et al. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico Diabetes Care 2001; 24(9): 1573–8
- Stern MP, Mitchell BD. Diabetes in Hispanic Americans. In: Diabetes in America. 2nd ed. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Diabetes Data Group. 1995: 631–59; NIH publication 95–1468
- Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study Diabetes 1996; 45(6): 742–8
- Gray RS, Fabsitz RR, Cowan LD, et al. Risk factor clustering in the insulin resistance syndrome: the Strong Heart Study. Am J Epidemiol 1998 148(9): 869–78
- Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356–9
- Hanis CL, Hewett-Emmett D, Bertin TK, et al. Origins of US Hispanics: implications for diabetes. Diabetes Care 1991; 14(7): 618–27
- Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286(10): 1195–200
- Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA 2002; 288 (14): 1728–32
- Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334(6): 374–81
- Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75(3): 809–17
- Meigs JB, D'Agostino RB Sr, Wilson PW, et al. Risk variable clustering in the insulin resistance syndrome: the Framingham Offspring Study. Diabetes 1997; 46(10): 1594–600
- Mazze R, Strock ES, Simonson G, et al. Staged diabetes management: a systematic approach. 2nd ed. London: John Wiley & Sons, 2004
- Alexander CM, Landsman PB, Teutsch SM, et al; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52(5): 1210–4
- Neufeld ND, Raffel LJ, Landon C, et al. Early presentation of type 2 diabetes in Mexican-American youth. Diabetes Care 1998; 21(1): 80–6
- Freinkel N. Banting Lecture 1980: of pregnancy and progeny. Diabetes 1980; 29(12): 1023–35
- Dabelea D, Hanson RL, Lindsay RS. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sib ships. Diabetes 2000; 49(12): 2208–11
- Meigs JB. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152(10): 908–11
- Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393–403
- Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin- dependent diabetes mellitus: problems and prospects. Endocr Rev 1998; 19(4): 477–90
- Mazze R, Strock E, Simonson G, et al. Staged diabetes management quick guide to the detection and treatment of diabetes. Minneapolis: International Diabetes Center, 2004